Mark Jackson

Mark Jackson is an accomplished executive with extensive experience in leadership roles across various sectors, including healthcare, technology, and finance. Currently serving as Chief Executive Officer at Medivault since April 2023, Jackson is instrumental in advancing the company's transition towards Health 3.0. Prior to this, Jackson held positions such as Director at Medicabis, where strategic development focused on all-natural therapeutics, and CEO & President at Lifelines Neuro, overseeing a successful 80-person med-tech operation. Additional experience includes advisory roles and senior leadership at Thomson Reuters, where Jackson drove significant growth initiatives across multiple global markets. Educational qualifications include attendance at MEDDIC Academy and West Herts College, complemented by a background in performing arts from The Barrow Group Performing Arts Center.